Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 214.50
Ask: 215.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.466%)
Open: 215.00
High: 217.00
Low: 213.00
Prev. Close: 215.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

15 Feb 2019 16:41

RNS Number : 2747Q
PureTech Health PLC
15 February 2019
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMDMGMZVKMGLZM
Date   Source Headline
7th Dec 20177:00 amRNSPRTC: Vedanta Enters Clinic/FDA Orphan Designation
5th Dec 20173:14 pmRNSIncrease of Holdings in Company
5th Dec 20177:00 amRNSPRTC's resTORbio Files IPO Registration Statement
4th Dec 20177:00 amRNSPureTech's Akili Pivotal ADHD Trial Successful
30th Nov 20177:00 amRNSPureTech's resTORbio Raises $40 Million
29th Nov 20177:00 amRNSPRTC's Vedanta Grows ImmunoOncology Collaborations
22nd Nov 20177:00 amRNSPureTech to Present at Piper Jaffray Conference
20th Nov 20177:00 amRNSPRTC's Clinical-Stage Anti-Aging Compound Advances
9th Nov 20177:00 amRNSPRTC to Present at Jefferies 2017 in London
3rd Nov 20177:00 amRNSPRTC: Vedanta Gets $5.4M for Antibiotic Resistance
1st Nov 20177:00 amRNSPRTC's Vedanta Licenses Microbiome IO Candidates
20th Oct 201712:07 pmRNSSecond Price Monitoring Extn
20th Oct 201712:02 pmRNSPrice Monitoring Extension
27th Sep 20177:00 amRNSPDMR DEALING - PURCHASE OF SHARES
26th Sep 20177:00 amRNSPDMR DEALING - PURCHASE OF SHARES
25th Sep 20177:00 amRNSResearch Update PRTC Gelesis Shows Efficacy/Safety
20th Sep 20177:00 amRNSPRTC Notes IP For Health Assessments from Speech
19th Sep 20177:00 amRNSPureTech Licenses Milk-Derived Exosome Technology
15th Sep 20177:00 amRNSPDMR DEALING - PURCHASE OF SHARES
7th Sep 20175:00 pmRNSDirector/PDMR Shareholding
4th Sep 20177:00 amRNSDirector/PDMR Shareholding
31st Aug 20177:00 amRNSTotal Voting Rights
30th Aug 20177:00 amRNSPureTech Health plc Half-year Report
29th Aug 20177:00 amRNSPureTech Licenses Glyph Lymphatic Technology
25th Aug 20175:11 pmRNSAdditional Listing
2nd Aug 20177:00 amRNSNotice of Results
31st Jul 20177:00 amRNSDirector/PDMR Shareholding
13th Jul 20177:00 amRNSPureTech Presents Inflammation-Targeting Data
12th Jul 20177:00 amRNSPRTC's Gelesis Notes Last Patient in Pivotal Study
3rd Jul 20177:00 amRNSPDMR DEALING - PURCHASE OF SHARES
28th Jun 20172:08 pmRNSPRTC's Akili Names Former Cubist CEO Exec Chairman
26th Jun 20177:00 amRNSPDMR DEALING - PURCHASE OF SHARES
16th Jun 20177:00 amRNSPDMR DEALING - PURCHASE OF SHARES
13th Jun 20176:05 pmRNSHolding(s) in Company
13th Jun 20176:01 pmRNSHolding(s) in Company
9th Jun 20175:40 pmRNSPDMR DEALING - PURCHASE OF SHARES
7th Jun 20177:00 amRNSPDMR DEALING - PURCHASE OF SHARES
31st May 20177:00 amRNSPDMR DEALING - PURCHASE OF SHARES
30th May 20177:00 amRNSPureTech's Vedanta Granted New US Patent
25th May 20177:00 amRNSPureTech Health to Present at Jefferies Conference
23rd May 20177:01 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd May 20177:00 amRNSDirector/PDMR Shareholding
19th May 20177:00 amRNSPureTech's Karuna to Present at 2 Medical Meetings
17th May 20177:00 amRNSPureTech's Sync Project Announces New Investors
16th May 20177:00 amRNSPureTech's Vedanta Granted Three New US Patents
9th May 20175:00 pmRNSResult of AGM
9th May 20177:00 amRNSPureTech Initiates Phase 2b mTORC1 Study in RTIs
9th May 20177:00 amRNSAnnual Capital Markets Meeting
5th May 20177:00 amRNSPureTech Announces License for Microbiome Therapy
5th May 20177:00 amRNSPDMR DEALING - PURCHASE OF SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.